pantoprazole has been researched along with voriconazole in 7 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (14.29) | 29.6817 |
2010's | 4 (57.14) | 24.3611 |
2020's | 2 (28.57) | 2.80 |
Authors | Studies |
---|---|
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Akers, KS; Boyd, NK; Niece, KL | 1 |
Arwood, MJ; Bulitta, J; Cavallari, LH; Hamadeh, IS; Klinker, KP; Mangal, N; Samant, TS; Schmidt, S | 1 |
Barbeito Castiñeiras, G; Bardán García, B; Belles Medall, D; Blanco Dorado, S; Blanco Hortas, A; Campos-Toimil, M; Carracedo, Á; Fernández-Ferreiro, A; Gómez Márquez, A; Lamas, MJ; Latorre-Pellicer, A; López-Vizcaíno, A; Maroñas Amigo, O; Otero Espinar, F; Pérez Del Molino Bernal, ML; Rodríguez Jato, MT; Zarra Ferro, I | 1 |
Ding, H; Hu, L; Huang, Q; Jiang, Y; Liu, Q; Liu, S; Yin, T | 1 |
1 review(s) available for pantoprazole and voriconazole
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
6 other study(ies) available for pantoprazole and voriconazole
Article | Year |
---|---|
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
In vitro study of the variable effects of proton pump inhibitors on voriconazole.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Antifungal Agents; Cytochrome P-450 CYP2C19; Cytochrome P-450 Enzyme System; Drug Interactions; Esomeprazole; Humans; Lansoprazole; Microsomes, Liver; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Rabeprazole; Voriconazole | 2015 |
Optimization of Voriconazole Therapy for the Treatment of Invasive Fungal Infections in Adults.
Topics: Adult; Aged; Antifungal Agents; Aspergillosis; Aspergillus; Candida; Candidiasis; Cytochrome P-450 CYP2C19; Drug Dosage Calculations; Drug Interactions; Drug Monitoring; Female; Genotype; Humans; Invasive Fungal Infections; Male; Microbial Sensitivity Tests; Middle Aged; Models, Biological; Pantoprazole; Pharmacogenomic Variants; Phenotype; Proton Pump Inhibitors; Risk Assessment; Voriconazole | 2018 |
A multicentre prospective study evaluating the impact of proton-pump inhibitors omeprazole and pantoprazole on voriconazole plasma concentrations.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Drug Interactions; Enzyme Inhibitors; Esomeprazole; Humans; Omeprazole; Pantoprazole; Prospective Studies; Proton Pump Inhibitors; Voriconazole | 2020 |
Effect of proton pump inhibitors on voriconazole concentrations in Chinese patients with malignant hematological diseases.
Topics: Cytochrome P-450 CYP2C19; Cytochrome P-450 CYP3A; Drug Interactions; Female; Humans; Lansoprazole; Male; Molecular Docking Simulation; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Retrospective Studies; Voriconazole | 2020 |